ArticleBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2012

Melphalan 180 mg/m2 can be safely administered as conditioning regimen before an autologous stem cell transplantation (ASCT) in multiple myeloma patients with creatinine clearance 60 mL/min/1.73 m2 or lower with use of palifermin for cytoprotection: results of a phase I trial.

Muneer H Abidi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.